Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival.

Autor: Xie, Tao1 (AUTHOR), Dickson, Kristie-Ann1 (AUTHOR), Yee, Christine1 (AUTHOR), Ma, Yue1 (AUTHOR), Ford, Caroline E.2 (AUTHOR), Bowden, Nikola A.3,4,5 (AUTHOR), Marsh, Deborah J.1,6 (AUTHOR) deborah.marsh@uts.edu.au
Zdroj: Cancers. Oct2022, Vol. 14 Issue 19, p4621. 23p.
Databáze: Academic Search Ultimate